Abstract:Objectives: The objectives were to examine the correlation between soluble Fas (sFas) level and apoptosis of T cells in peripheral blood and peritoneal fluid of patients with ovarian carcinoma and to investigate the possible sFas effect on T cell apoptosis.Study design: Patients with stages I-II ovarian carcinoma (n = 10) and patients with stages III-IV ovarian carcinoma (n = 22), as well as ovarian benign tumors (n = 8), were enrolled in the study. Apoptosis of and Fas expression on T cells from peripheral blood and peritoneal fluids were assessed by flow cytometry. Soluble Fas level was assayed using an ELISA kit. The effects of peritoneal fluid on Jurkat cell apoptosis with or without depletion of sFas were evaluated and compared in vitro.Results: The sFas level and apoptosis of T cells in peripheral blood and peritoneal fluid from stages III-IV ovarian carcinoma were significantly higher than those from stages I-II ovarian carcinoma (p < 0.01 in all instances) and benign ovarian tumor (p < 0.01 in all instances). In peritoneal fluid, the sFas level and apoptosis of T cells from stages I-II ovarian carcinoma were significantly higher than those from benign ovarian tumor (p < 0.01 in all instances), and the Fas expression on T cells from ovarian carcinoma were higher than those from benign ovarian tumor (p < 0.05 in all instances). There was a positive correlation between the sFas level and the apoptosis of T cells in peritoneal fluids from stages III-IV ovarian carcinoma (r = 0.647, p = 0.001). Peritoneal fluid of ovarian carcinoma could induce significant Jurkat cell apoptosis. The blocking of Fas expression on the Jurkat cell surface, but not the deletion of sFas, may remarkably restrain the apoptosis level.Conclusions: Elevated sFas is correlated with apoptosis of T cells in peripheral blood and peritoneal fluid from ovarian carcinoma. Soluble Fas evidently does not affect T cell apoptosis, which is probably due to elevated Fas expression on T cells. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

[Detection of Cell Apoptosis Induced with Anti-Fas Antibody in Bladder Carcinoma Cell Line by Single Cell Gel Electrophoresis].

Anti-Fas on Lung Carcinoma Cell Line A-549:level of Fas is a Predictive Marker of Biological Responsiveness

[Apoptosis of Lymphocytes Induced by Fas/FasL of Colon Cancer Cells].

The biological effect of Fas Ligand transfected HepG2 cell

Analysis of Fas and Fas Ligand expression and function in lung cancer cell lines

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

Induction of Apoptosis in Human Lung Cancer Cell Line A-549 by Anti-Fas Monoclonal Antibody

Expression Of Fas/Fasl And C-Myc In Bladder Cancer And Their Correlation With Tumor Immune Function

[Expression of Fas in Six Human Urogenital Malignant Cell Lines].

Transfection of Apoptosis Related Gene Fas Ligand in Human Hepatocellular Carcinoma Cells and Its Significance in Apoptosis

Correlation Between Soluble Fas Level and Apoptosis of T Cells in Ovarian Carcinoma.

Cervical carcinoma cell apoptosis and the expression of Fas and Fas ligand in human

Detection of Fas/APO-1 in Six Human Urogenital Malignant Cell Lines with Flow Cytometry

Fas Ligand Expression in Colon Cancer: A Possible Mechanism of Tumor Immune Privilege

[Interferon-gamma up-regulates Fas expression and increases Fas-mediated apoptosis in tumor cell lines].

[Expression of Fas Ligand on Peritumoral Lymphocytes and Its Association with Apoptosis of Colorectal Carcinomas].

Over-expressed Fas Improves the Apoptosis of Malignant T-cells in Vitro and Vivo.

Tissue Microarray Technology for Analysis of the Significance of Fas-FasL System in Cell Apoptosis of Colon Adenocarcinoma

[Expression of Fas Ligand in Urogenital Malignant Cell Lines and Renal Cell Carcinoma].

Effect of Fas Ligand Gene Transfection in Hela Cell on the Induction of Lymphocyte Apoptosis

[Relationship of Apoptosis and Expression of Fas Gene in Tongue Squamous Cell Carcinoma Cell Line Tca8113].